Prednisolone Sulfacetamide (Blephamide, Blephamide S.o.p.) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Prednisolone Sulfacetamide products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A combination of a corticosteroid and an antibiotic used for eye inflammation with infection.
Products affected
1 / 3
In shortage since
Apr 15, 2016
Reports on file
11
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
ODAN-CIDE
5MG
100MG · SOLUTION · ODAN LABORATORIES LTD
DIN 00630640 · since Apr 15, 2016, no end estimate · Disruption of the manufacture of the drug.
To be discontinued
BLEPHAMIDE
0.2%
10% · DROPS · ALLERGAN INC
DIN 00807788
Resolved
BLEPHAMIDE
10%
0.2% · DROPS · ALLERGAN INC
DIN 00807788 · ended May 25, 2021 · Disruption of the manufacture of the drug.
Resolved
BLEPHAMIDE
10%
0.2% · DROPS · ALLERGAN INC
DIN 00807788 · ended Apr 6, 2020 · Disruption of the manufacture of the drug.
Resolved
BLEPHAMIDE
0.2%
10% · DROPS · ALLERGAN INC
DIN 00807788 · ended Nov 8, 2019 · Disruption of the manufacture of the drug.
Resolved
BLEPHAMIDE OPH ONT
0.2%
10% · OINTMENT · ALLERGAN INC
DIN 00307246 · ended Nov 8, 2019 · Product has been discontinued
Discontinued
BLEPHAMIDE S.O.P.
0.2%
10% · OINTMENT · ALLERGAN INC
DIN 00307246
Resolved
BLEPHAMIDE OPHT SUSPENSION
0.2%
10% · DROPS · ALLERGAN INC
DIN 00807788 · ended Apr 18, 2019 · Disruption of the manufacture of the drug.
Resolved
BLEPHAMIDE OPHT SUSPENSION
0.2%
10% · DROPS · ALLERGAN INC
DIN 00807788 · ended Apr 12, 2019 · Disruption of the manufacture of the drug.
Resolved
BLEPHAMIDE OPHT SUSPENSION
0.2%
10% · DROPS · ALLERGAN INC
DIN 00807788 · ended Apr 20, 2018 · Global Production Delay
Resolved
BLEPHAMIDE OPHT SUSPENSION
0.2%
10% · DROPS · ALLERGAN INC
DIN 00807788 · ended Apr 20, 2018 · Global Production Delay
What's happening
Prednisolone Sulfacetamide is currently affected by an active shortage report filed with Health Canada by ODAN LABORATORIES LTD.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Prednisolone Sulfacetamide is classified under “ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB” (ATC S01CA).
Recent changes
No changes recorded yet.
Common questions
What is Prednisolone Sulfacetamide used for?
A combination of a corticosteroid and an antibiotic used for eye inflammation with infection.
When will Prednisolone Sulfacetamide be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Prednisolone Sulfacetamide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.